🇺🇸 Q10 Coenzyme in United States

15 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 22 April 2025 – 22 April 2026
• Total reports: 15

Most-reported reactions

1. Headache — 3 reports (20%)
2. Insomnia — 3 reports (20%)
3. Dizziness — 2 reports (13.33%)
4. Alopecia — 1 report (6.67%)
5. Arthralgia — 1 report (6.67%)
6. Back Pain — 1 report (6.67%)
7. Blood Sodium Abnormal — 1 report (6.67%)
8. Burning Sensation — 1 report (6.67%)
9. Chemical Burn Of Gastrointestinal Tract — 1 report (6.67%)
10. Constipation — 1 report (6.67%)

Source database →

Frequently asked questions

Is Q10 Coenzyme approved in United States?

Q10 Coenzyme does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Q10 Coenzyme in United States?

Central Hospital, Nancy, France is the originator. The local marketing authorisation holder may differ — check the official source linked above.